Location History:
- Marcoussis, FR (2015)
- Paris, FR (2016)
Company Filing History:
2 out of 5,076 
2 out of 32 
2 out of 5 
Years Active: 2015-2016
Title: Innovations of Jean-Christophe Galas
Introduction
Jean-Christophe Galas is a notable inventor based in Paris, France. He has made significant contributions to the field of microfluidics, particularly in systems designed to control the concentration of molecules for stimulating targets such as living cells. With a total of two patents to his name, his work showcases the intersection of technology and biological applications.
Latest Patents
Galas's latest patents include a microfluidic system for controlling a concentration profile of molecules capable of stimulating a target. This invention involves a microfluidic device that comprises at least one microfluidic channel equipped with inlet and outlet orifices for fluid. The system also features a chamber or another microfluidic channel designed to receive the target, along with a microporous membrane that facilitates the diffusion of stimulating molecules. His second patent focuses on a microfluidic system for controlling the concentration of molecules, characterized by a network of openings in the microfluidic channel and a microporous membrane covering these openings. This innovative design allows for precise control over the delivery of stimulating molecules to the target.
Career Highlights
Throughout his career, Jean-Christophe Galas has worked with prestigious institutions such as the Centre National de la Recherche Scientifique and École Normale Supérieure. His experience in these organizations has contributed to his expertise in microfluidic technologies and their applications in biological research.
Collaborations
Some of his notable coworkers include Maxime Dahan and Mathieu Morel. Their collaborative efforts have likely enhanced the development and application of Galas's innovative technologies.
Conclusion
Jean-Christophe Galas is a prominent inventor whose work in microfluidics has the potential to advance the field of biological research significantly. His patents reflect a commitment to innovation and the application of technology in life sciences.